Asset comparator
Compare stocks, ETFs, indices, commodities, cryptocurrencies and bonds over the same period. Indicators that are not meaningful for a given asset type are flagged.
- Thermo Fisher Scientific
- Merck & Co.
Performance comparée (base 100)
Chaque actif vaut 100 au 13 octobre 2025 ; une valeur de 120 signifie +20 % depuis cette date (dernière date commune : 9 octobre 2026).
Indicateurs
« Sans objet » signale un indicateur qui n'a pas de sens pour ce type d'actif : il ne faut pas le comparer.
| Indicateur | Thermo Fisher ScientificStock | Merck & Co.Stock |
|---|---|---|
| Performance et risque | ||
| Performance over the periodChange in price between the first and last common dates. | +25.4% | +69.9% |
| Annualized performanceAverage annual return that would produce the same total performance. | +25.8% | +71.0% |
| Annualized volatilityTypical range of price movements: the higher it is, the more the price fluctuates. | 29.1% | 29.3% |
| Maximum DrawdownLargest decline from peak to subsequent trough over the period. | −31.5% | −11.9% |
| Sharpe RatioReturn achieved above the risk-free rate (5.24%), per unit of volatility. The higher it is, the better risk was rewarded over the period. | 0.89 | 2.50 |
| 1-day 95% Value at RiskOne-day loss that was exceeded in only 5% of cases (historical VaR). | −2.7% | −2.4% |
| Fondamentaux | ||
| Market capitalizationTotal market value of all shares (or circulating tokens for a crypto). | 243.3B $ | 359.22B $ |
| P/E (trailing 12 months)Share price divided by earnings per share: number of years of earnings paid. | 35.4 | 115.6 |
| Price-to-SalesMarket capitalization divided by annual revenue. | 5.3 | 5.4 |
| Net marginShare of revenue retained as profit. | 15.0% | 4.8% |
| Return on equityReturn on equity (ROE). | 13.5% | 7.0% |
| Revenue growthOver one year, latest published quarter compared with the same quarter of the previous year. | +10.5% | +5.1% |
| Dividend yieldAnnual dividend relative to the share price. | 0.29% | 2.39% |
| Debt / equityFinancial debt relative to shareholders' equity. | 81% | 128% |
Corrélations sur la période
De −1 à 1 : proche de 1, les deux actifs montent et baissent ensemble ; proche de 0, ils évoluent indépendamment.
- Thermo Fisher Scientific / Merck & Co.0,17
Analyse comparative
Analyse générée par IAL'IA compare les actifs sélectionnés à partir des seuls chiffres ci-dessus, en signalant ce qui n'est pas comparable. Le texte n'est généré qu'à votre demande.
Informations fournies à titre pédagogique. Elles ne constituent ni un conseil en investissement ni une recommandation personnalisée. Les performances passées ne préjugent pas des performances futures.